Insights from BCC Research

Laurie L. Sullivan

Recent Posts

Among Other Apps, Smart Pills Could Help Staunch the Opioid Epidemic

Posted by Laurie L. Sullivan on Jun 22, 2017 10:00:00 AM

Smart pills are increasingly influencing our health. They are noninvasive and have redefined diagnosis, disease monitoring, and treatment adherence. By 2021, US sales of smart pills may double, reaching $1.2 billion. The global market for smart pills is poised to exceed a 20% compound annual growth rate (CAGR) during the next five years, according to BCC Research’s recent study, Smart Pills: Applications and Global Markets. High-growth application areas include capsule endoscopy, patient monitoring, and delivery of therapeutic agents. The adoption of advanced ingestible medical sensor technologies is a key growth driver.

Read More

Topics: Life Sciences, Pharmaceuticals

Gut Instinct: The Human Microbiome Predicts Response to Therapy

Posted by Laurie L. Sullivan on Jun 15, 2017 11:15:00 AM
The human microbiome is a significant commercial opportunity for the life sciences sector. Scientific studies have clearly shown the role of the microbiome in the pathogenesis of many mainstream diseases. Microbiome-based drugs and diagnostics are being studied in a wide range of disorders, including cancers, gastrointestinal or gut conditions, Crohn’s disease and colitis, dental problems, and chronic infections. Exploiting the human microbiome could help fill gaps in the conventional treatment options for disease. Rare or orphan diseases that are not currently addressed by pharmaceutical companies are another area of emphasis worldwide.

Market Highlights from BCC Research
Read More

Topics: Life Sciences, Biotechnology

Blood Industry Gets a Transfusion from an Aging Population

Posted by Laurie L. Sullivan on Jun 5, 2017 11:00:00 AM

1PHM1199B-blood.jpgEnsuring safety of the blood supply, the demand for plasma-derived therapeutics, and an aging population are factors driving growth in the global blood industry. The annual growth of plasma-derived therapies, used mostly to treat rare disorders, may exceed 10%. Hemophilia, hepatitis, cancer, and kidney failure are among the many conditions that are managed by blood transfusion or by therapy with plasma or plasma-derived products. An aging population suggests that there will be many more patients who need such products in the future. At a compound annual growth rate (CAGR) of 4.9%, BCC Research predicts the value of the global blood industry to increase from $33.5 billion in 2016 to $42.6 billion in 2021.

Read More

Topics: Life Sciences, Healthcare

Latest Advances in Bionics: Hands That Can See, Robots That Can Feel

Posted by Laurie L. Sullivan on May 25, 2017 10:00:00 AM

BCC Research recently analyzed the global market for bionic devices, assessing the latest sensor and material technologies that are being used in advanced bionic ears, eyes, hearts, limbs, and exoskeletons. These bionic components are driving market growth and changing the lives of millions of people.

Read More

Topics: Life Sciences, Healthcare